Reed Elsevier Adds AstraZeneca PLC CEO David Brennan as a Director
Published: Feb 16, 2012
Reed Elsevier Plc (ENL, REL.L) Thursday announced that Mr David Brennan has been appointed as a non-executive director of the company. The company stated that David Brennan will assume office with effect from 1 November 2012, subject to shareholder approval at the respective Annual General Meetings to be held on 24 and 25 April 2012. Mr Brennan is currently the Chief Executive Officer of AstraZeneca PLC, a global biopharmaceutical company, which develops, manufactures and markets prescription medicines.